Related Experiment Video
Updated: Nov 30, 2025
08:13
Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
Published on: January 20, 2019
22.2K
SARS-CoV-2 Vaccines: Inactivation by Gamma Irradiation for T and B Cell Immunity
Arno Mullbacher1, Julian Pardo2, Yoichi Furuya3
1Department of Immunology and Infectious Disease, John Curtin School for Medical Research, Australian National University, Canberra 0200, ACT, Australia.
Pathogens (Basel, Switzerland)
|November 13, 2020
Summary
Cytotoxic T cells offer long-term COVID-19 protection, unlike antibody-focused vaccines. Gamma-ray irradiation could create a novel vaccine inducing balanced B and T cell immunity for better viral defense.
Area of Science:
- Immunology
- Vaccinology
- Virology
Background:
- Preclinical data highlight cytotoxic T cell importance in viral infections.
- Current COVID-19 vaccine development predominantly targets antibody responses.
- A gap exists in vaccines eliciting robust T cell-mediated immunity.
Purpose of the Study:
- To discuss the potential of cytotoxic T cells for long-term COVID-19 protection.
- To propose gamma-ray irradiation as a method for developing a novel COVID-19 vaccine.
- To advocate for vaccines inducing balanced humoral (B cell) and cellular (T cell) immunity.
Main Methods:
- Review of preclinical data on T cell immunity in viral infections.
- Discussion of vaccine strategies focusing on T cell responses.
- Proposal of gamma-ray irradiation for vaccine preparation.
Main Results:
- Cytotoxic T cells may provide durable immunity against SARS-CoV-2.
- Gamma-ray irradiation is a viable inactivation method for vaccine development.
- Balanced immunity involving both B and T cells is achievable.
Conclusions:
- Vaccine strategies should consider the role of cytotoxic T cells for enhanced COVID-19 protection.
- Gamma-ray irradiated vaccines represent a promising avenue for balanced immune response induction.
- Further research into T cell-centric vaccines is warranted for improved pandemic preparedness.
More Related Videos
Related Concept Videos
01:51Vaccinations
49.7K
Overview
49.7K
01:30Cancer Vaccines
726
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
726
01:27Tumor Immunotherapy
955
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
955
01:27Cytotoxic T Cells-mediated Immune Response
6.2K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.2K